Explore 3 Stock Ideas & Industry Insights Download Free Report

Earnings

Why Did MercadoLibre (NASDAQ:MELI) Net Income Rise 6% While Operating Income Fell 6%?

Key HighlightsNet revenues and financial income were USD 10,750 million, up 45% year over year and 41% on an FX-neutral basis, with Brazil showing the strongest performance.Income from operations fell 6% to USD 676 million, a 6.3%Marginthat was 40 basis points below the second …

Vinay Lochav | 05 November 2026

How Did American Bitcoin (NASDAQ:ABTC) Swing to a USD 126 Million Profit on Falling Revenue?

Key HighlightsAmericanBitcoin(NASDAQ:ABTC) reported third-quarterNet Incomeof USD 126.0 million, or USD 1.73 per diluted share, against USD 3.5 million, or USD 0.06, a year earlier, after restating for the 1-for-15 reverse split.A gain on digitalAssetsof USD 197.3 million drove the swing, as Bitcoin's quarter-endFair Valueof …

Vinay Lochav | 05 November 2026

What Drove Acadia Pharmaceuticals (NASDAQ:ACAD) DAYBUE Sales Up 39% While EPS Fell to USD 0.31?

Income from operations rose to USD 71.7 million from USD 35.8 million, so the lowerBottom Linedid not come from the core business. The difference was tax: Acadia recorded an income tax expense of USD 26.9 million this quarter against a benefit of USD 27.2 …

Vinay Lochav | 05 November 2026

Why Did MNTN, Inc. (NYSE:MNTN) Collapse 54% After a CEO Change and Lower 2026 Outlook?

Chief Financial Officer Patrick Pohlen said revenue was impacted by unforeseen execution problems in the go-to-market organization, and the company said the updated outlook reflects the realignment of its sales organization. Weisman said theBusinessneeds operational rigor and a culture of accountability. Published coverage reported …

Vinay Lochav | 05 November 2026

Why Did Acadia Healthcare (NASDAQ:ACHC) Earnings Slip to USD 0.38 Despite 5.1% Revenue Growth?

Net income attributable to the company was USD 34.5 million versus USD 36.2 million, so diluted earnings fell to USD 0.38 from USD 0.40. The cause sits below the operating lines: income tax was USD 17.8 million compared with USD 1.7 million, because the …

Vinay Lochav | 05 November 2026

Can Ascent Industries (NASDAQ:ACNT) Sustain 37.8% Sales Growth After Flipping to a USD 0.15 Profit?

Operating income was USD 1.6 million versus an operating loss of USD 0.8 million, andNet Incomefrom continuing operations was USD 1.4 million compared with a loss of USD 0.1 million. Gross margin fell to 26.2% of sales from 29.7% even as gross profit increased, …

Vinay Lochav | 05 November 2026

What Pushed ACRES Commercial Realty (NYSE:ACR) to a USD 5.16 Loss After Buying Its Manager?

Key HighlightsACRES Commercial Realty (NYSE:ACR) reported a third-quarterGAAPnet loss allocable to common shares of USD 56.3 million, or USD 5.16 per diluted share, against income of USD 9.8 million, or USD 1.34, a year earlier.Earnings available for distribution, a non-GAAP measure, were a loss …

Vinay Lochav | 05 November 2026

How Does Enact Holdings (NASDAQ:ACT) Plan to Return About USD 600 Million After a USD 1.15 Quarter?

Key HighlightsEnact Holdings (NASDAQ:ACT) reported third-quarterNet Incomeof USD 159 million, or USD 1.15 per diluted share, while adjustedOperating Incomewas USD 164 million, or USD 1.19 per share.The company raised its 2026Capitalreturn expectation to approximately USD 600 million and declared a quarterlyDividendof USD 0.24 a …

Vinay Lochav | 05 November 2026

Why Did BuzzFeed, Inc. (NASDAQ:BZFD) Tumble 38% After Third Quarter Revenue Fell 44%?

Chairman and Chief Executive Byron Allen called it a transitional quarter. Following the Allen Family Digital majority stake completed in May 2026, a July restructuring cut about 35% of workforce and dedicated contractors, targeting USD 30 million of annualized savings. Management is focusing on …

Vinay Lochav | 05 November 2026

Why Did ADMA Biologics (NASDAQ:ADMA) Gross Margin Jump to 70.8% While BIVIGAM Sales Fell 35.2%?

Cost of product revenue fell to USD 41.2 million from USD 58.6 million, mainly because normal source plasma sales, a lower-margin line, stopped and BIVIGAMVolumedeclined. Management also credits theYieldenhancement process approved by the FDA in April 2025, which it says raises ASCENIV and BIVIGAM …

Vinay Lochav | 05 November 2026
Support

Hi! How can we help you today?

Loading…